
CAS 1032754-81-6
:Formel:C21H28N8O3S2
InChl:InChI=1S/C21H28N8O3S2/c1-14-16(13-27-3-5-29(6-4-27)34(2,30)31)33-18-17(14)25-19(15-11-23-21(22)24-12-15)26-20(18)28-7-9-32-10-8-28/h11-12H,3-10,13H2,1-2H3,(H2,22,23,24)
InChI Key:AKKCGLXULFRAET-UHFFFAOYSA-N
SMILES:CC1=C(SC2=C1N=C(N=C2N3CCOCC3)C4=CN=C(N=C4)N)CN5CCN(CC5)S(=O)(=O)C
Filtern nach
Reinheitsanteil
0
100
|
0
|
50
|
90
|
95
|
100
6 Produkte gefunden.
- Niedrigster Preis
- Höchster Preis
- Niedrigste Reinheit
- Höchste Reinheit
- Schnellste Lieferung
5-(7-Methyl-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinothieno[3,2-d]pyrimidin-2-yl)pyrimidin-2-amine
CAS:Formel:C21H28N8O3S2Reinheit:98%Farbe und Form:SolidMolekulargewicht:504.6288GNE-477
CAS:GNE-477 is a potent and efficacious dual PI3K/mTOR inhibitor.Formel:C21H28N8O3S2Reinheit:98.88% - 99.55%Farbe und Form:SolidMolekulargewicht:504.629GNE-477
CAS:5-(7-Methyl-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinothieno[3,2-d]pyrimidin-2-yl)pyrimidin-2-amineFormel:C21H28N8O3S2Reinheit:99%Molekulargewicht:504.63GNE-477
CAS:GNE-477 is a small molecule with pharmacological properties that has been shown to inhibit the growth of cancer cells in vitro and in vivo. GNE-477 has been shown to inhibit autophagy, which may be responsible for its potent anticancer activity. GNE-477 also inhibits the activation of nuclear DNA and lipid kinase, inhibiting the production of proteins necessary for cell division. This drug is used to treat autoimmune diseases, skin cancer, and squamous carcinoma. GNE-477 also has anti-inflammatory properties that may be due to its inhibition of the epidermal growth factor receptor (EGFR).Formel:C21H28N8O3S2Reinheit:Min. 95%Molekulargewicht:504.63 g/mol





